These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 22507677)

  • 1. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.
    Huang H; Xi H; Chen L; Zhang F; Liu Y
    Cell Transplant; 2012; 21 Suppl 1():S23-31. PubMed ID: 22507677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury.
    Huang H; Wang H; Chen L; Gu Z; Zhang J; Zhang F; Song Y; Li Y; Tan K; Liu Y; Xi H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Apr; 20(4):434-8. PubMed ID: 16683451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury.
    Huang H; Chen L; Wang H; Xiu B; Li B; Wang R; Zhang J; Zhang F; Gu Z; Li Y; Song Y; Hao W; Pang S; Sun J
    Chin Med J (Engl); 2003 Oct; 116(10):1488-91. PubMed ID: 14570607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury.
    Rao Y; Zhu W; Guo Y; Jia C; Qi R; Qiao R; Cao D; Zhang H; Cui Z; Yang L; Wang Y
    Cell Transplant; 2013; 22 Suppl 1():S21-5. PubMed ID: 23992752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients].
    Huang H; Chen L; Xi H; Wang Q; Zhang J; Liu Y; Zhang F
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):14-20. PubMed ID: 19192871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor recovery following olfactory ensheathing cell transplantation in rats with spinal cord injury.
    Tharion G; Indirani K; Durai M; Meenakshi M; Devasahayam SR; Prabhav NR; Solomons C; Bhattacharji S
    Neurol India; 2011; 59(4):566-72. PubMed ID: 21891935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study.
    Saberi H; Derakhshanrad N; Yekaninejad MS
    Cell Transplant; 2014; 23 Suppl 1():S19-23. PubMed ID: 25302604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries.
    Chen L; Huang H; Xi H; Zhang F; Liu Y; Chen D; Xiao J
    Cell Transplant; 2014; 23 Suppl 1():S35-44. PubMed ID: 25333925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury.
    Wu J; Sun T; Ye C; Yao J; Zhu B; He H
    Cell Transplant; 2012; 21 Suppl 1():S33-7. PubMed ID: 22507678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI.
    Huang H; Chen L; Wang H; Xi H; Gou C; Zhang J; Zhang F; Liu Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Apr; 20(4):439-43. PubMed ID: 16683452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous olfactory ensheathing cell transplantation in human spinal cord injury.
    Féron F; Perry C; Cochrane J; Licina P; Nowitzke A; Urquhart S; Geraghty T; Mackay-Sim A
    Brain; 2005 Dec; 128(Pt 12):2951-60. PubMed ID: 16219671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury.
    Tabakow P; Jarmundowicz W; Czapiga B; Fortuna W; Miedzybrodzki R; Czyz M; Huber J; Szarek D; Okurowski S; Szewczyk P; Gorski A; Raisman G
    Cell Transplant; 2013; 22(9):1591-612. PubMed ID: 24007776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial.
    Wu JC; Huang WC; Chen YC; Tu TH; Tsai YA; Huang SF; Huang HC; Cheng H
    J Neurosurg Spine; 2011 Sep; 15(3):216-27. PubMed ID: 21663406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of granulocyte colony-stimulating factor (G-CSF) administration for postrehabilitated motor complete spinal cord injury patients: an open-label, phase I study.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Eskandari G; Mardani A; Rahdari F; Meybodi KT
    Cell Transplant; 2013; 22 Suppl 1():S139-46. PubMed ID: 23992648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury.
    Lima C; Escada P; Pratas-Vital J; Branco C; Arcangeli CA; Lazzeri G; Maia CA; Capucho C; Hasse-Ferreira A; Peduzzi JD
    Neurorehabil Neural Repair; 2010 Jan; 24(1):10-22. PubMed ID: 19794133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations.
    Chen L; Chen D; Xi H; Wang Q; Liu Y; Zhang F; Wang H; Ren Y; Xiao J; Wang Y; Huang H
    Cell Transplant; 2012; 21 Suppl 1():S65-77. PubMed ID: 22507682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis.
    Chen L; Huang H; Zhang J; Zhang F; Liu Y; Xi H; Wang H; Gu Z; Song Y; Li Y; Tan K
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Sep; 21(9):961-6. PubMed ID: 17933231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat.
    García-Alías G; López-Vales R; Forés J; Navarro X; Verdú E
    J Neurosci Res; 2004 Mar; 75(5):632-41. PubMed ID: 14991839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on repair of subacute spinal cord injury by transplantation of olfactory ensheathing cells combined with chondroitinase ABC in adult rats].
    Zhang C; He X; Lan B; Li H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):8-13. PubMed ID: 19192870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.